Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease

被引：60

作者：

Alpay, M ^{[1
]}

Koroshetz, WJ

机构：

[1] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA

[2] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA

来源：

PSYCHOSOMATICS | 2006年 / 47卷 / 01期

关键词：

D O I：

10.1176/appi.psy.47.1.70

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

The effect of quetiapine (an atypical antipsychotic with minimal extrapyramidal side effects) on motor as well as behavioral symptoms was studied in five consecutive patients with Huntington's disease in a long-term facility. Improvement of behavioral symptoms (i.e., psychotic symptoms, agitation, irritability, and insomnia) without worsening of motor functioning were noted.

引用

页码：70 / 72

页数：3

共 10 条

[1]

CAINE ED, 1983, AM J PSYCHIAT, V140, P728

[2]

CUDKOWICZ M, 1999, HUNTINGTONS DIS MOVE, P155

[3] Effectiveness of risperidone in Huntington chorea patients [J].

Dallocchio, C ;

Buffa, C ;

Tinelli, C ;

Mazzarello, P .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (01) :101-103

[4] The use of olanzapine for movement disorder in Huntington's disease: a first case report [J].

Dipple, HC .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (01) :123-124

[5] PATTERNS OF CELL LOSS IN HUNTINGTONS-DISEASE [J].

KOWALL, NW ;

FERRANTE, RJ ;

MARTIN, JB .

TRENDS IN NEUROSCIENCES, 1987, 10 (01) :24-29

[6] A NOVEL GENE CONTAINING A TRINUCLEOTIDE REPEAT THAT IS EXPANDED AND UNSTABLE ON HUNTINGTONS-DISEASE CHROMOSOMES [J].

MACDONALD, ME ;

AMBROSE, CM ;

DUYAO, MP ;

MYERS, RH ;

LIN, C ;

SRINIDHI, L ;

BARNES, G ;

TAYLOR, SA ;

JAMES, M ;

GROOT, N ;

MACFARLANE, H ;

JENKINS, B ;

ANDERSON, MA ;

WEXLER, NS ;

GUSELLA, JF ;

BATES, GP ;

BAXENDALE, S ;

HUMMERICH, H ;

KIRBY, S ;

NORTH, M ;

YOUNGMAN, S ;

MOTT, R ;

ZEHETNER, G ;

SEDLACEK, Z ;

POUSTKA, A ;

FRISCHAUF, AM ;

LEHRACH, H ;

BUCKLER, AJ ;

CHURCH, D ;

DOUCETTESTAMM, L ;

ODONOVAN, MC ;

RIBARAMIREZ, L ;

SHAH, M ;

STANTON, VP ;

STROBEL, SA ;

DRATHS, KM ;

WALES, JL ;

DERVAN, P ;

HOUSMAN, DE ;

ALTHERR, M ;

SHIANG, R ;

THOMPSON, L ;

FIELDER, T ;

WASMUTH, JJ ;

TAGLE, D ;

VALDES, J ;

ELMER, L ;

ALLARD, M ;

CASTILLA, L ;

SWAROOP, M .

CELL, 1993, 72 (06) :971-983

[7]

Menza M M, 1999, Ann Clin Psychiatry, V11, P141, DOI 10.1023/A:1022360027358

[8] Hypokinesia in Huntington's disease [J].

vanVugt, JPP ;

vanHilten, BJ ;

Roos, RA .

MOVEMENT DISORDERS, 1996, 11 (04) :384-388

[9] Clozapine versus placebo in Huntington's disease: A double blind randomised comparative study [J].

vanVugt, JPP ;

Siesling, S ;

Vergeer, M ;

vanderVelde, EA ;

Roos, RAC .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (01) :35-39

[10]

WOODCOCK JH, 1999, BEHAV ASPECTS HUNTIN, P115

← 1 →